Clinical trials have demonstrated new, safe, efficacious ways to use these cardiovascular agents: Beta-blockers are now first-line treatment for heart failure, and the HOPE trial showed that ACE inhibitors reduce morbidity and mortality in patients at high risk of cardiac events.
|Original language||English (US)|
|Number of pages||23|
|State||Published - 2000|
ASJC Scopus subject areas
- Leadership and Management